Review · 6 min read

WatchPAT One: Sleep Tracking Data and Specifications

WatchPAT One review built from ZOLL Itamar's published product information. FDA-cleared disposable home sleep apnea test based on Peripheral Arterial Tone (PAT). Manufacturer states 89% correlation with PSG.

Summary of Findings

Evidence summary: WatchPAT One

No peer-reviewed PSG validation studies for the WatchPAT One are in the CircaTest corpus. This is an honest null result. CircaTest does not substitute manufacturer white papers, influencer reviews, or benchmarks from earlier generations of the same product line. When peer-reviewed validation appears, it will be added here automatically.

How CircaTest evaluates studies →

Data Sources and Methodology

This review compiles data from ZOLL Itamar's published WatchPAT One product information (itamar-medical.com, verified April 6, 2026) and the FDA 510(k) database. No first-person testing was conducted.

Important caveat upfront: ZOLL Itamar's product information states WatchPAT One has 89% correlation to PSG and a 98% success rate (less than 2% failure during data acquisition and analysis). CircaTest has not separately verified this figure against the underlying clinical validation publications. Multiple peer-reviewed validation studies of WatchPAT exist but are not yet imported into the CircaTest corpus, so the validation studies section below may show no studies until they are added.

FDA Status

WatchPAT is FDA-cleared as a portable home sleep apnea test (HSAT) and is also accepted by the U.S. Department of Transportation for commercial driver sleep apnea screening. Verify the specific clearance scope against the FDA 510(k) database before relying on it.

Sensor Suite

Per ZOLL Itamar's published product information, WatchPAT One measures up to 7 different signals via a 3-points-of-contact design (finger probe, wrist unit, chest sensor):

  • PAT (Peripheral Arterial Tone): the proprietary signal that WatchPAT uses. It measures arterial volume changes at the fingertip to reflect sympathetic nervous system activity associated with respiratory events. PAT is the basis for the FDA clearance.
  • Heart rate.
  • Oximetry (blood oxygen / SpO2).
  • Actigraphy (motion): via accelerometer.
  • Body position.
  • Snoring.
  • Chest motion.

The device does not include PPG (it uses PAT instead), ECG, EDA, temperature, altimeter, or GPS sensors.

Sleep Apnea and Sleep Architecture

ZOLL Itamar describes the WatchPAT algorithm as detecting both obstructive and central sleep apnea and calculating REM, deep, and light sleep architecture from PAT-derived signals. Sleep apnea detection is the primary purpose of the device. Light, deep, and REM staging are reported but the device does not produce a consumer-style sleep score and does not include a smart alarm. Nap detection is not relevant; this is a single-night-of-sleep test, not a continuous tracker.

Health Features

  • Resting heart rate: tracked.
  • Respiratory rate: tracked.
  • Blood oxygen (SpO2): tracked.
  • Sleep apnea detection: primary purpose, FDA-cleared.
  • HRV, body temperature, menstrual cycle, stress, readiness, strain, recovery: not provided.

Hardware

  • Form factor: polymer wrist unit with finger probe and chest sensor. Single-use disposable. The disposability is the key product differentiator from ZOLL Itamar's reusable WatchPAT product line. It eliminates the logistics of cleaning, recharging, and returning equipment.
  • Weight: specific weight not extracted from a verified ZOLL Itamar source.
  • Battery: built-in and not user-serviceable; the device is single-use.
  • Display: none.

Subscription and Cost

WatchPAT One is sold through clinical channels (sleep clinics, telehealth providers, prescription sleep test services) rather than direct consumer retail. Per-test pricing typically ranges from $200 to $400 via telehealth providers but varies by provider and insurance. CircaTest does not maintain a single verified consumer price. There is no subscription.

Compatibility

WatchPAT One pairs with iOS and Android via the WatchPAT companion app for data upload. Apple Health, Google Fit, and Strava integrations are not supported; this is a single-night clinical test, not a fitness tracker.

Who It Is For (Based on the Data)

  • Adults whose primary care provider, sleep clinic, or telehealth provider has ordered a home sleep apnea test
  • Commercial drivers who need a DOT-accepted sleep apnea screen
  • Patients who want a single-night, no-cleaning, no-return-shipping HSAT option
  • Sleep clinics and telehealth providers building disposable HSAT workflows

The device's data profile is not aligned with everyday consumer sleep tracking. It is a one-night diagnostic test, not a fitness tracker. Consumers looking for ongoing nightly sleep tracking with eventual sleep apnea screening should look at the Withings Sleep Rx instead, which is also FDA-cleared for OSA and is reusable.

Products Mentioned

WatchPAT One

Disposable single-use FDA-cleared home sleep apnea test by ZOLL Itamar. PAT signal plus oximetry, heart rate, actigraphy, body position, snoring, and chest motion. Manufacturer states 89% PSG correlation and 98% success rate. Per-test pricing typically $200 to $400 via telehealth providers but varies by provider and insurance. CircaTest does not maintain an affiliate link because this is a prescription-required medical device sold via clinical channels.

Not medical advice. This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Home sleep apnea tests must be ordered and interpreted by a qualified clinician. If you have sleep concerns, consult a qualified healthcare provider.